Funds holding Candel Therapeutics Inc
ISIN US1374041093 · United States
- Fund holders
- 104
- Of which ETFs
- 14 90 other funds
- Value held
- 86.6M $
- Share of capital
- 21.8 % of 76.5M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 33 | 161.7 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 63 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 53.9 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 4 | 19.6 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.58 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 0.45 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.28 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.19 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.02 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 104 | +6 | 16,675,210 | +24.1 % |
| 2026Q1 | 98 | +2 | 13,435,402 | +5.4 % |
| 2025Q4 | 96 | +3 | 12,748,605 | +8.2 % |
| 2025Q3 | 93 | 0 | 11,784,205 | +14.6 % |
| 2025Q2 | 93 | +21 | 10,286,357 | +242.7 % |
| 2025Q1 | 72 | +4 | 3,001,883 | +26.5 % |
| 2024Q4 | 68 | +39 | 2,372,825 | +55.2 % |
| 2024Q3 | 29 | +19 | 1,528,530 | +63.8 % |
| 2024Q2 | 10 | 0 | 933,283 | -8.4 % |
| 2024Q1 | 10 | -2 | 1,019,206 | -33.7 % |
| 2023Q4 | 12 | 1,537,315 |
Institutional managers
109 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 10,987,017 | 53.8M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 6,422,018 | 31.5M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 3,497,948 | 17.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,109,042 | 15.2M $ | as of Mar 31, 2026 |
| Saturn V Capital Management LP | 2,896,588 | 14.2M $ | as of Mar 31, 2026 |
| Portolan Capital Management, LLC | 2,894,325 | 14.2M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,125,000 | 5.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,060,086 | 5.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,035,435 | 5.1M $ | as of Mar 31, 2026 |
| Halter Ferguson Financial Inc. | 904,051 | 4.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 818,558 | 4M $ | as of Mar 31, 2026 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 775,000 | 3.8M $ | as of Mar 31, 2026 |
| Sands Capital Alternatives, LLC | 405,837 | 2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 323,154 | 1.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 227,521 | 1.1M $ | as of Mar 31, 2026 |
| Ghisallo Capital Management LLC | 200,000 | 980K $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 200,000 | 980K $ | as of Mar 31, 2026 |
| Tanager Wealth Management LLP | 198,175 | 971.1K $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 171,978 | 845.3K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 156,700 | 767.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 149,855 | 734.3K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 136,266 | 667.7K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 112,973 | 553.6K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 111,716 | 547.4K $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 107,211 | 525.3K $ | as of Mar 31, 2026 |
Declared shareholders of Candel Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 8.80 % | 6,422,018 | as of Mar 31, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 4.20 % | 3,079,861 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Candel Therapeutics Inc". https://titelia.com/en/stocks/candel-therapeutics-inc-US1374041093